Back
Garmin Ltd. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
40
GRMN
Garmin Ltd.
Last Price:
$205.02
Seasonality Move:
3.17%
Buy
67
KYMR
Kymera Therapeutics, Inc.
Last Price:
$78.08
Seasonality Move:
-9.68%
Sell
40
Garmin Ltd. (GRMN)
is a Sell
Is Garmin Ltd. a Buy, Sell or Hold?
-
The current Garmin Ltd. [GRMN] share price is $205.60. The Score for GRMN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
GRMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $80.35. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GRMN Stock Price Chart
What is Garmin Ltd.'s stock price today?
-
The Garmin Ltd. share price today is $205.60The current trend is relatively stagnant and GRMN is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $80.35The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
GRMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 51.45 | Buy |
| Chaikin Money Flow: | -72779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (196.44 - 207.12) | Buy |
| Bollinger Bands (100): | (203.45 - 246.13) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.03 | Buy |
| Relative Strength Index (14 RSI): | 54.68 | Buy |
| Chaikin Money Flow: | -224422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.91 - 87.31) | Buy |
| Bollinger Bands (100): | (45.04 - 72.82) | Buy |
GRMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 203.8 | Buy |
| 20-day SMA: | 203.84 | Buy |
| 50-day SMA: | 209.27 | Sell |
| 200-day SMA: | 215.68 | Sell |
| 8-day EMA: | 204.73 | Buy |
| 20-day EMA: | 204.09 | Buy |
| 50-day EMA: | 209.7 | Sell |
| 200-day EMA: | 213.91 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.3 | Sell |
| 20-day SMA: | 80.34 | Buy |
| 50-day SMA: | 69.42 | Buy |
| 200-day SMA: | 47.86 | Buy |
| 8-day EMA: | 82.24 | Sell |
| 20-day EMA: | 79.61 | Buy |
| 50-day EMA: | 71.43 | Buy |
| 200-day EMA: | 53.99 | Buy |
Garmin Ltd. Earnings Growth & GRMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and an increase next year of $0.54 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.25 per share.
Garmin Ltd. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||